Technology News and Research

RSS

iDashboards urges healthcare organizations to update their Information Technology systems

The debate surrounding the current state of US healthcare and its impending reform should not detract healthcare organizations from their ultimate goal of providing superior care to their patients.

9 Sep 2009

Bioluminescence imaging demystifies causes of infectious diseases

By attaching light-emitting genes to infectious bacteria in an experimental system, researchers at University College, Cork, Ireland, have been able to track where in the body the bacteria go - giving an insight into the path of the infection process leading to the development of more targeted treatments.

9 Sep 2009

Prostate cancer treatment options discussed in a study

A new study in the Journal of the American Medical Association (JAMA) appears to support the theory outlined in earlier studies that men with more advanced forms of prostate cancer don't benefit from a combination of hormone and radiation therapy.

9 Sep 2009

Dr. Terry Collins offers public lecture on the growing field of green chemistry

Consumer concerns over hazardous chemicals in the air and water have led scientists to find solutions in the new field of green chemistry. "The most troubling health effects are associated with endocrine disrupting chemicals (EDCs) that may interfere with cellular development in humans and animals," says Dr. Terry Collins, a champion in the field.

9 Sep 2009

Thermo Fisher Scientific receives Ringier Technology Innovation Award

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has received a Ringier Technology Innovation Award for its role in helping Chinese laboratories quickly develop melamine detection capabilities following the discovery of melamine-tainted milk and infant formula in China. The award was presented by Ringier Trade Publishing, which publishes China's leading food industry magazine, Food Manufacturing Journal.

From Thermo Fisher Scientific Inc. 9 Sep 2009

Merck KGaA acquires Suzhou Taizhu Technology Development for € 28 million

Merck KGaA announced today that it has acquired Suzhou Taizhu Technology Development Co. Ltd. ("Taizhu"), a leading supplier of effect pigments located in Taicang near Shanghai, China. With total revenues of more than € 14 million in 2008 and 300 employees Taizhu is one of the biggest effect pigments companies in the Chinese market. The acquisition is of high strategic importance to the Merck pigments business.

9 Sep 2009

Lockton forms health reform advisory practice to help clients deal with changes in health system

Lockton Companies, the world's largest private insurance broker, is offering insights on the impact of health reform through its newly formed Lockton Health Reform Advisory Practice. Lockton's new team provides employers with information, advice, and practical approaches as they respond to health reform legislation and understand impact on their employees and businesses.

9 Sep 2009

Light can be manipulated for creative and lucrative ends

The speed of light, 300 million metres per second, was long thought an immutable constant and has defined our understanding of matter and energy but recent research in the area of optics and photonics is proving that we can manipulate light to some ingenious and hugely lucrative ends.

9 Sep 2009

European Dynamic Annuloplasty Activation study completes patient enrollment

MiCardia (MiCardia Corporation, Irvine, California) today announced the completion of enrollment in its European “DYANA” (Dynamic Annuloplasty Activation) study, designed to support submission for CE mark of the firm’s Dynaplasty technology in Europe.

9 Sep 2009

Humana implements Application Security's DbProtect to manage critical information

Application Security, Inc., the leading provider of database security, risk and compliance solutions for the enterprise, today announced that Humana Inc. has successfully implemented DbProtect™ to manage and safeguard the highly sensitive, critical information stored on its database servers.

9 Sep 2009

Nexus launches Healthcare Practice

Nexus, a leading provider of advanced technology and network integration, announced the launch of a focused Healthcare Practice. Healthcare is one of the fastest growing industries today and currently generates a large percentage of Nexus' revenue.

9 Sep 2009

Stocks of Medizone begin trading on the OTC Bulletin Board

Developer of ground-breaking ozone-based hospital sterilization technology -- AscepticSure(TM), Medizone announced today that its common stock has begun trading on the OTC Bulletin Board (OTC Bulletin Board: MZEI). The company's common stock was previously quoted on the Pink Sheets.

9 Sep 2009

Space-age technology to combat counterfeit pharmaceuticals

University of Leicester researchers have combined crime research and space-age technology in ways that could lead to the quick detection of counterfeit pharmaceuticals in a black market currently worth an estimated $40billion per year.

9 Sep 2009

New procedure for transapical valve replacement minimizes trauma and blood loss

Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced today the first successful clinical use of its new lower-profile Ascendra 2 transapical delivery system, designed to benefit both patients and physicians by minimizing trauma and blood loss, and facilitating transcatheter heart valve delivery and deployment.

9 Sep 2009

NIH awards Vaxart $2.8M grant to develop an orally-delivered H5N1 Avian influenza vaccine

Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has been awarded a $2.8 million phase II Small Business Innovation Research grant from the National Institute of Allergy and Infectious Disease (National Institutes of Health) to support development of its first product, an orally-delivered vaccine for H5N1 Avian influenza.

9 Sep 2009

Can-Fite's Phase II clinical study of CF101 provides positive results

Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today that its 75-patient Phase II clinical study with CF101 to treat patients with moderate to severe Psoriasis has successfully met its primary objectives.

9 Sep 2009

Online destination resource for diabetics

Bayer Diabetes Care is continuing to simplify life for people with diabetes with the launch of simplewins.com, an online destination designed to inspire people with diabetes and help them meet the day-to-day challenges of living with and managing the disease.

9 Sep 2009

FDA approves Cochlear's Nucleus 5 System

Cochlear, the global leader in implantable hearing solutions, announced today that the U.S. Food and Drug Administration (FDA) has approved the Nucleus((R) )5 System for adults and children with severe-to-profound hearing loss.

9 Sep 2009

Covidien acquires Power Medical Interventions

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of Power Medical Interventions Inc. (PMI) for an aggregate consideration of approximately $65 million, including assumption of debt.

9 Sep 2009

AMS adds a 3.5 cm Occlusive Cuff to its product line

American Medical Systems, Inc. (AMS), a trusted provider of medical solutions for restoring men’s and women’s pelvic health, announced today that it has expanded its AMS 800 male artificial urinary sphincter product line with the addition of a 3.5 cm Occlusive Cuff to restore urinary continence to a wider range of male patients.

9 Sep 2009